SCD
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Clinical Trials (1)
Total enrollment: 200 patients across 1 trials
A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
200 patients
Phase 2Completed
Related Jobs
Senior Director, Global Value & Access Strategy, Head Pricing & Analytics Group
Boston, MA
2w ago
$232K - $348K/yr
Director, Compliance Business Partner
Boston, MA
2w ago
$200K - $300K/yr
Associate Director FP&A, Clinical Accounting & Data Analysis
Boston, MA
2w ago
$156K - $234K/yr
Senior Director, Global Value & Access Strategy – Povetacicept Lead
Boston, MA
3w ago
$240K - $360K/yr
Distribution Strategy Associate Director - Pain
Boston, MA
1mo ago
$148K - $222K/yr
Market Research & Insights Associate Director
Boston, MA
2mo ago
$158K - $237K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.